Free Trial

Royalty Pharma (RPRX) SEC Filings & 10K Form

Royalty Pharma logo
$36.50 +0.04 (+0.11%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$36.66 +0.16 (+0.45%)
As of 04:31 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Royalty Pharma SEC Filings

DateFilerForm TypeView
08/14/2025
7:30 AM
GENERAL ATLANTIC, L.P. (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
08/13/2025
11:49 AM
Capital International Investors (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G
08/08/2025
3:58 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
4:00 PM
Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2025
3:52 PM
Royalty Pharma (Issuer)
Urist Marshall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2025
8:30 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2025
6:10 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/05/2025
10:56 AM
MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
07/31/2025
7:42 PM
Ho Carole (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2025
7:45 PM
Royalty Pharma (Issuer)
WEATHERMAN ELIZABETH H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/25/2025
3:23 PM
Royalty Pharma (Issuer)
WEATHERMAN ELIZABETH H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
07/17/2025
7:40 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2025
4:06 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2025
4:05 PM
Legorreta Pablo G. (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13D
05/20/2025
3:49 PM
Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:51 PM
Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2025
3:52 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
4:22 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
4:41 PM
Engelbert Catherine M. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:04 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:06 PM
Coric Vlad (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:07 PM
DESOUZA ERROL B (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:08 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:09 PM
HODGSON DAVID C (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:11 PM
LOVE TED W (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
4:12 PM
Norden Gregory (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/12/2025
9:39 AM
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
05/09/2025
4:07 PM
Royalty Pharma (Issuer)
Urist Marshall (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:10 PM
Coyne Terrance P. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:14 PM
Hite Christopher (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:15 PM
Lloyd George W. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2025
4:18 PM
Legorreta Pablo G. (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/08/2025
8:14 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2025
6:31 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/02/2025
5:19 PM
Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
Form SCHEDULE 13D/A
04/21/2025
4:43 PM
Coric Vlad (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/21/2025
4:40 PM
Coric Vlad (Reporting)
Royalty Pharma (Issuer)
Form 3/A
04/21/2025
4:18 PM
Royalty Pharma (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/11/2025
8:15 AM
Royalty Pharma (Filer)
Form DEFA14A
04/11/2025
7:45 AM
Royalty Pharma (Filer)
Form DEFM14A
04/11/2025
7:50 AM
Royalty Pharma (Filer)
Form ARS
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.

All the details are waiting for you now — but you need to act before the September 1st funding windo
04/11/2025
7:53 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2025
3:17 PM
Royalty Pharma (Filer)
Form DEFA14A
04/10/2025
3:06 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2025
4:45 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2025
4:46 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
4:25 PM
Royalty Pharma (Filer)
Form DEFA14A
02/21/2025
3:30 PM
Royalty Pharma (Subject)
Severgnini Achille G. (Filed by)
Form SCHEDULE 13D/A
02/13/2025
5:03 AM
Royalty Pharma (Filer)
Form PREM14A
02/12/2025
8:30 AM
FMR LLC (Filed by)
Royalty Pharma (Subject)
Form SCHEDULE 13G/A
02/11/2025
6:38 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/17/2025
4:12 PM
Royalty Pharma (Filer)
Form DEFA14A
01/16/2025
4:15 PM
Royalty Pharma (Filer)
Form DEFA14A
01/15/2025
4:04 PM
Royalty Pharma (Subject)
Form 425
01/13/2025
7:40 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:42 AM
Royalty Pharma (Filer)
Form DEFA14A
01/10/2025
4:21 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
4:26 PM
Royalty Pharma (Filer)
Form DEFA14A
01/10/2025
6:47 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2024
3:05 PM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
2:15 PM
MORGAN STANLEY (Filed by)
Royalty Pharma (Subject)
Form SC 13G/A
11/06/2024
8:24 AM
Royalty Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:35 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/30/2024
4:07 PM
Fernandez Henry A (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
4:08 PM
Bassler Bonnie L (Reporting)
Royalty Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/27/2024
7:39 AM
Royalty Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RPRX) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners